Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
376.71
451.77
354.26
325.72
264.86
298.01
290.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
376.71
451.77
354.26
325.72
264.86
298.01
290.08
Raw Material Cost
108.75
102.15
73.00
64.12
66.17
59.82
67.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.51
4.91
4.30
4.39
4.53
4.54
4.52
Selling and Distribution Expenses
57.88
63.33
46.09
41.61
42.36
42.25
41.24
Other Expenses
2.01
2.70
1.30
1.31
1.03
1.59
1.39
Total Expenditure (Excl Depreciation)
192.19
197.37
136.34
123.28
123.33
122.51
126.89
Operating Profit (PBDIT) excl Other Income
184.5
254.4
217.89999999999998
202.39999999999998
141.5
175.5
163.2
Other Income
1.32
2.43
5.33
6.89
6.82
7.25
6.47
Operating Profit (PBDIT)
219.57
283.51
243.72
229.79
168.80
203.17
190.03
Interest
5.51
4.91
4.30
4.39
4.53
4.54
4.52
Exceptional Items
0.00
-352.76
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
267.96
349.62
281.26
261.60
198.70
238.19
222.90
Depreciation
33.73
26.68
20.46
20.46
20.45
20.41
20.36
Profit Before Tax
180.33
-100.85
218.96
204.94
143.83
178.21
165.15
Tax
30.28
40.74
43.73
39.78
25.73
41.20
28.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
150.05
-141.59
175.22
165.16
118.09
137.01
137.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
150.05
-141.59
175.22
165.16
118.09
137.01
137.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
150.05
-141.59
175.22
165.16
118.09
137.01
137.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
219.64
48.81
503.92
332.75
482.27
363.82
452.70
Earnings per share (EPS)
1.22
-1.2
1.43
1.33
0.93
1.06
1.05
Diluted Earnings per share
1.22
-1.2
1.43
1.33
0.93
1.06
1.05
Operating Profit Margin (Excl OI)
48.98%
56.31%
61.51%
62.15%
53.44%
58.89%
56.26%
Gross Profit Margin
56.82%
-16.42%
67.58%
69.2%
62.02%
66.65%
63.95%
PAT Margin
39.83%
-31.34%
49.46%
50.71%
44.59%
45.98%
47.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -16.62% vs 27.52% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 205.93% vs -180.82% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -22.38% vs 17.91% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 12.24% vs 13.95% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Halozyme Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
376.71
1,371.00
-994.29
-72.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
376.71
1,371.00
-994.29
-72.52%
Raw Material Cost
108.75
724.00
-615.25
-84.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.51
73.00
-67.49
-92.45%
Selling and Distribution Expenses
57.88
381.00
-323.12
-84.81%
Other Expenses
2.01
2.40
-0.39
-16.25%
Total Expenditure (Excl Depreciation)
192.19
1,202.00
-1,009.81
-84.01%
Operating Profit (PBDIT) excl Other Income
184.52
169.00
15.52
9.18%
Other Income
1.32
8.00
-6.68
-83.50%
Operating Profit (PBDIT)
219.57
349.00
-129.43
-37.09%
Interest
5.51
73.00
-67.49
-92.45%
Exceptional Items
0.00
-17.00
17.00
100.00%
Gross Profit (PBDT)
267.96
647.00
-379.04
-58.58%
Depreciation
33.73
172.00
-138.27
-80.39%
Profit Before Tax
180.33
87.00
93.33
107.28%
Tax
30.28
30.00
0.28
0.93%
Provisions and contingencies
0
0
0.00
Profit After Tax
150.05
57.00
93.05
163.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
150.05
57.00
93.05
163.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
150.05
57.00
93.05
163.25%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
219.64
6,500.00
-6,280.36
-96.62%
Earnings per share (EPS)
1.22
0.11
1.11
1,009.09%
Diluted Earnings per share
1.22
0.11
1.11
1,009.09%
Operating Profit Margin (Excl OI)
48.98%
12.33%
0.00
36.65%
Gross Profit Margin
56.82%
18.89%
0.00
37.93%
PAT Margin
39.83%
4.16%
0.00
35.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 37.67 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -16.62% vs 27.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 42.20% vs 35.22% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 15.00 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 205.93% vs -180.82% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 27.01% vs 53.78% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.82 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -22.38% vs 17.91% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 34.69% vs 40.02% in Mar 2025
Quarterly - Interest
Interest 0.55 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 12.24% vs 13.95% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 22.22% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 48.98%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
